CN Stock MarketDetailed Quotes

Chengdu Olymvax Biopharmaceuticals Inc (688319)

Watchlist
  • 28.37
  • +0.07+0.25%
Market Closed Mar 26 15:00 CST
11.51BMarket Cap179.56P/E (TTM)

Chengdu Olymvax Biopharmaceuticals Inc (688319) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Main business305.11M99.76%
Other business736.41K0.24%

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry586.1M99.53%
Other business2.75M0.47%

By Country/Region

Currency:CNY
2024/FY
Stock NameRevenueRatio
East China229.3M38.94%
Central China114.62M19.46%
Southwest87.46M14.85%
North China60.44M10.26%
South China58.45M9.93%
Northwest22.32M3.79%
Northeast China13.52M2.30%
Other business2.75M0.47%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the prospect of a ceasefire negotiation between the US and Iran has been dominating market sentiment. On March 26 EST, President T Show More